Vinpocetine-induced stimulation of calcium-activated potassium currents in rat pituitary GH3 cells

Biochem Pharmacol. 2001 Apr 1;61(7):877-92. doi: 10.1016/s0006-2952(01)00553-6.

Abstract

The effects of vinpocetine, an inhibitor of cyclic GMP phosphodiesterase, on ionic currents were examined in rat pituitary GH3 lactotrophs with the aid of the patch-clamp technique. In GH3 cells bathed in normal Tyrode's solution, vinpocetine (10 microM) reversibly increased the amplitude of Ca2+-activated K+ current (I(K)Ca) with an EC50 value of 4 microM. When the recording pipettes were filled with 10 mM EGTA, vinpocetine also stimulated I(K)Ca. In the cell-attached configuration, application of vinpocetine to the bath increased the activity of large-conductance Ca2+-activated K+ (BK(Ca)) channels. In excised membrane patches, application of vinpocetine (10 microM) to the bath did not change the single-channel conductance of BK(Ca) channels; however, it did increase channel activity. In the inside-out configuration, neither 8-bromo cyclic GMP nor YC-1 applied intracellularly affected BK(Ca) channel activity. The vinpocetine-induced change in the kinetic behavior of BK(Ca) channels was due to an increase in mean open time and a decrease in mean closed time. Vinpocetine (10 microM) caused a leftward shift in the midpoint for the voltage-dependent opening. Under the current-clamp mode, vinpocetine (10 microM) decreased the firing rate of spontaneous action potentials induced by thyrotropin-releasing hormone (10 microM) in GH3 cells. In pheochromocytoma PC12 cells, vinpocetine (10 microM) applied intracellularly also enhanced the activity of BK(Ca) channels without altering single-channel conductance. Thus, the present study suggests that vinpocetine-mediated stimulation of I(K)Ca may result from the direct activation of BK(Ca) channels and indirectly from elevated cytosolic Ca2+.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels / metabolism
  • Cyclic GMP / analogs & derivatives*
  • Cyclic GMP / pharmacology
  • Drug Interactions
  • Electrophysiology
  • Enzyme Activators / pharmacology
  • Indazoles / pharmacology
  • Kinetics
  • Large-Conductance Calcium-Activated Potassium Channels
  • Membrane Potentials / drug effects
  • PC12 Cells
  • Pheochromocytoma / metabolism
  • Pheochromocytoma / pathology
  • Pituitary Gland / drug effects*
  • Pituitary Gland / metabolism
  • Pituitary Gland / physiology
  • Potassium Channels / drug effects
  • Potassium Channels / metabolism*
  • Potassium Channels / physiology
  • Potassium Channels, Calcium-Activated*
  • Rats
  • Tumor Cells, Cultured
  • Vinca Alkaloids / pharmacology*

Substances

  • Calcium Channel Blockers
  • Calcium Channels
  • Enzyme Activators
  • Indazoles
  • Large-Conductance Calcium-Activated Potassium Channels
  • Potassium Channels
  • Potassium Channels, Calcium-Activated
  • Vinca Alkaloids
  • 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole
  • 8-bromocyclic GMP
  • vinpocetine
  • Cyclic GMP